ARUN SREEKUMAR to Neoplasm Proteins
This is a "connection" page, showing publications ARUN SREEKUMAR has written about Neoplasm Proteins.
Connection Strength
0.963
-
ERR1 and PGC1a associated mitochondrial alterations correlate with pan-cancer disparity in African Americans. J Clin Invest. 2019 03 28; 129(6):2351-2356.
Score: 0.479
-
Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res. 2001 Oct 15; 61(20):7585-93.
Score: 0.143
-
Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma. PLoS One. 2011 Mar 23; 6(3):e17177.
Score: 0.069
-
Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. Mol Cell Proteomics. 2010 Feb; 9(2):298-312.
Score: 0.062
-
Humoral response profiling reveals pathways to prostate cancer progression. Mol Cell Proteomics. 2008 Mar; 7(3):600-11.
Score: 0.055
-
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood. 2007 Dec 15; 110(13):4445-54.
Score: 0.054
-
Differential phosphoprotein mapping in cancer cells using protein microarrays produced from 2-D liquid fractionation. Anal Chem. 2006 Feb 01; 78(3):702-10.
Score: 0.048
-
Using protein microarrays to study cancer. Biotechniques. 2002 Dec; Suppl:46-53.
Score: 0.039
-
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood. 2009 Sep 24; 114(13):2733-43.
Score: 0.015